Skip to content
Operation Infinite Justice – Lifestyle
Author:
Integrated BioPharma, Inc.
Integrated Biopharma’s Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of Operations
August 20, 2026
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
May 8, 2026